WallStreetZenWallStreetZen

NASDAQ: MEDP
Medpace Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MEDP

Based on 9 analysts offering 12 month price targets for Medpace Holdings Inc

Min Forecast
$305.00-47.82%
Avg Forecast
$465.22-20.42%
Max Forecast
$655.00+12.05%

Should I buy or sell MEDP stock?

Based on 9 analysts offering ratings for Medpace Holdings Inc.

Sell
Strong Buy
0 analysts 0%
Buy
1 analysts 11.11%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
3 analysts 33.33%
Although MEDP's forecast from analysts indicates a "Sell", our proven Zen Rating quant model rates MEDP as a "Buy". Stocks with a Zen Rating of Buy have had an average return of +19.88% per year. Learn More

Be the first to know when Wall Street analysts revise their MEDP stock forecasts and price targets.

MEDP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-24
lockedlocked$00.00+00.00%2025-10-24
lockedlocked$00.00+00.00%2025-10-24
lockedlocked$00.00+00.00%2025-09-09
lockedlocked$00.00+00.00%2025-09-03
UBS
Top 12%
89
Strong SellDowngrades$305.00-47.82%2025-07-29
Truist Securities
Bottom 1%
1
HoldMaintains$436.00-25.42%2025-07-23
Deutsche Bank
Bottom 6%
6
HoldMaintains$430.00-26.44%2025-07-23
Baird
Top 24%
77
HoldMaintains$490.00-16.18%2025-07-23

1 of 1

Forecast return on equity

Is MEDP forecast to generate an efficient return?

Company
186.56%
Industry
11.26%
Market
146.17%
MEDP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MEDP forecast to generate an efficient return on assets?

Company
31.25%
Industry
14.8%
MEDP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MEDP earnings per share forecast

What is MEDP's earnings per share in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$14.35-2.12%
Avg 2 year Forecast
$15.69+7.02%
Avg 3 year Forecast
$17.25+17.65%
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MEDP revenue forecast

What is MEDP's revenue in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$2.5B+6.56%
Avg 2 year Forecast
$2.7B+16.05%
Avg 3 year Forecast
$3.0B+26.1%
MEDP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MEDP earnings growth forecast

How is MEDP forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
5.49%
Industry
16.37%
Market
40.98%
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MEDP revenue growth forecast

How is MEDP forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
8.01%
Industry
5.62%
Market
25.27%
MEDP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MEDP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MEDP vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MEDP$584.57$465.22-20.42%Sell
ILMN$95.03$113.50+19.44%Hold
DGX$174.78$197.91+13.23%Hold
ICLR$165.95$208.27+25.50%Buy
WAT$343.47$352.13+2.52%Buy
View Top Diagnostic & Research Stocks

Medpace Holdings Stock Forecast FAQ

Is Medpace Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: MEDP) stock is to Sell MEDP stock.

Out of 9 analysts, 0 (0%) are recommending MEDP as a Strong Buy, 1 (11.11%) are recommending MEDP as a Buy, 5 (55.56%) are recommending MEDP as a Hold, 0 (0%) are recommending MEDP as a Sell, and 3 (33.33%) are recommending MEDP as a Strong Sell.

If you're new to stock investing, here's how to buy Medpace Holdings stock.

What is MEDP's earnings growth forecast for 2025-2027?

(NASDAQ: MEDP) Medpace Holdings's forecast annual earnings growth rate of 5.49% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 16.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.

Medpace Holdings's earnings in 2025 is $433,008,000.On average, 15 Wall Street analysts forecast MEDP's earnings for 2025 to be $404,180,198, with the lowest MEDP earnings forecast at $381,499,145, and the highest MEDP earnings forecast at $428,269,662. On average, 15 Wall Street analysts forecast MEDP's earnings for 2026 to be $441,919,983, with the lowest MEDP earnings forecast at $401,926,740, and the highest MEDP earnings forecast at $490,380,594.

In 2027, MEDP is forecast to generate $485,831,426 in earnings, with the lowest earnings forecast at $435,328,619 and the highest earnings forecast at $540,365,106.

What is MEDP's revenue growth forecast for 2025-2027?

(NASDAQ: MEDP) Medpace Holdings's forecast annual revenue growth rate of 8.01% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.27%.

Medpace Holdings's revenue in 2025 is $2,358,373,000.On average, 15 Wall Street analysts forecast MEDP's revenue for 2025 to be $70,786,744,399, with the lowest MEDP revenue forecast at $66,815,024,956, and the highest MEDP revenue forecast at $74,476,781,612. On average, 15 Wall Street analysts forecast MEDP's revenue for 2026 to be $77,096,426,351, with the lowest MEDP revenue forecast at $69,800,856,594, and the highest MEDP revenue forecast at $86,082,089,488.

In 2027, MEDP is forecast to generate $83,772,295,202 in revenue, with the lowest revenue forecast at $72,843,024,678 and the highest revenue forecast at $96,560,668,444.

What is MEDP's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: MEDP) forecast ROA is 31.25%, which is higher than the forecast US Diagnostics & Research industry average of 14.8%.

What is MEDP's Price Target?

According to 9 Wall Street analysts that have issued a 1 year MEDP price target, the average MEDP price target is $465.22, with the highest MEDP stock price forecast at $655.00 and the lowest MEDP stock price forecast at $305.00.

On average, Wall Street analysts predict that Medpace Holdings's share price could fall to $465.22 by Oct 24, 2026. The average Medpace Holdings stock price prediction forecasts a potential downside of 20.42% from the current MEDP share price of $584.57.

What is MEDP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: MEDP) Medpace Holdings's current Earnings Per Share (EPS) is $14.66. On average, analysts forecast that MEDP's EPS will be $14.35 for 2025, with the lowest EPS forecast at $13.54, and the highest EPS forecast at $15.20. On average, analysts forecast that MEDP's EPS will be $15.69 for 2026, with the lowest EPS forecast at $14.27, and the highest EPS forecast at $17.41. In 2027, MEDP's EPS is forecast to hit $17.25 (min: $15.45, max: $19.18).

What is MEDP's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: MEDP) forecast ROE is 186.56%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.